Tuberculosis (TB) is a major cause of morbidity and mortality worldwide. It is estimated that
25% of the world's population are infected with Mycobacterium tuberculosis, with a 5–10 …

There is an urgent need for new and better drugs to treat tuberculosis due to lengthy and
complex treatment regimens and a rising problem of drug resistance. Drug discovery efforts …

Tuberculosis (TB) is a life-threatening infectious disease caused by Mycobacterium
tuberculosis (M. tuberculosis). Timely diagnosis and effective treatment are essential in the …

The “WHO operational handbook on tuberculosis. Module 3: Diagnosis-Rapid diagnostics
for tuberculosis detection, third edition” is the latest edition replacing the one issued in 2021 …

Tuberculosis (TB) is a major public health issue worldwide, with~ 9.6 million new incident
cases and 1.5 million deaths in 2014. The End-TB Strategy launched by the World Health …

Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid,
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …

Highly effective drugs for treating TB were introduced over 30 years ago, yet deaths from the
disease continue to increase. New tools are needed, including drugs with activity against …

Despite substantial success in implementing standardized care and improving rates of cure
in recent years, the global burden of tuberculosis (TB) remains enormous. Lack of rapid and …

Introduction: Tuberculosis remains a global health problem and pharmacokinetic variability
has been postulated as one of the causes of treatment failure and acquired drug resistance …

Tuberculosis (TB) is one of the world's most important infectious causes of morbidity and
mortality among adults. Between 8 and 9 million develop TB disease, and approximately 2 …